Vivani Medical, Inc. (VANI) Stock

Vivani Medical, Inc. (VANI) is a Healthcare stock trading at $1.41 (as of 2026-08-20), with a market capitalization of $121.16M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Vivani Medical, Inc. develops medical implants intended to treat chronic conditions and address unmet medical needs. Its portfolio includes miniature drug implants designed to deliver more stable drug exposure and implantable visual prostheses intended to provide functional artificial vision for individuals with blindness.

Valuation — source: SEC EDGAR (first-party)
Price$1.41
Market Cap$121.16M
Price / Book6.39
FCF Yield-35.7%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$0.00
Financial Health — source: SEC EDGAR
Altman Z-Score-4.23 (distress)
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.6
Industry P/E (Medical Equipment)32.9
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($1.91M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOAdam Mendelsohn
Employees37
CountryUS
IPO Date2014-11-19

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Stereotaxis, Inc. (STXS)
  • FONAR Corporation (FONR)
  • electroCore, Inc. (ECOR)
  • Hyperfine, Inc. (HYPR)
  • Streamex Corp. (STEX)
  • Outset Medical, Inc. (OM)
  • NeurAxis, Inc. (NRXS)
  • Precision Optics Corporation, Inc. (POCI)
VANI earnings history · VANI institutional & insider holders · VANI KPIs & operating metrics · VANI financials · VANI investor presentations & press releases · VANI SEC filings · VANI peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.